{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:48:42Z","timestamp":1775605722896,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10-12","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009410","name":"Southern California Clinical and Translational Science Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00726-019-02794-3","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T11:26:23Z","timestamp":1571225183000},"page":"1569-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-2484","authenticated-orcid":false,"given":"Hossein","family":"Jadvar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Peng","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivetta","family":"Vorobyova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis S.","family":"Markland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"issue":"5","key":"2794_CR1","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.eururo.2011.12.028","volume":"61","author":"N Agarwal","year":"2012","unstructured":"Agarwal N, Sonpavde G, Sternberg CN (2012) Novel molecular targets for the therapy of castration-resistant prostate cancer. Eur Urol 61(5):950\u2013960. https:\/\/doi.org\/10.1016\/j.eururo.2011.12.028","journal-title":"Eur Urol"},{"issue":"8","key":"2794_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1021\/bc900537f","volume":"21","author":"H Cai","year":"2010","unstructured":"Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti PS (2010) Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. Bioconjug Chem 21(8):1417\u20131424. https:\/\/doi.org\/10.1021\/bc900537f","journal-title":"Bioconjug Chem"},{"key":"2794_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7150\/thno\/v01p0189","volume":"1","author":"K Chen","year":"2011","unstructured":"Chen K, Chen X (2011a) Integrin targeted delivery of chemotherapeutics. Theranostics 1:189\u2013200","journal-title":"Theranostics"},{"issue":"1","key":"2794_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.seminoncol.2010.11.005","volume":"38","author":"K Chen","year":"2011","unstructured":"Chen K, Chen X (2011b) Positron emission tomography imaging of cancer biology: current status and future prospects. Semin Oncol 38(1):70\u201386. https:\/\/doi.org\/10.1053\/j.seminoncol.2010.11.005","journal-title":"Semin Oncol"},{"issue":"7","key":"2794_CR5","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1073\/pnas.87.7.2471","volume":"87","author":"MS Dennis","year":"1990","unstructured":"Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA (1990) Platelet glycoprotein IIb\u2013IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci USA 87(7):2471\u20132475","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2794_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2310\/7290.2009.00010","volume":"8","author":"H Jadvar","year":"2009","unstructured":"Jadvar H (2009) Molecular imaging of prostate cancer: a concise synopsis. Mol Imaging 8(2):56\u201364","journal-title":"Mol Imaging"},{"issue":"2","key":"2794_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2214\/ajr.12.8816","volume":"199","author":"H Jadvar","year":"2012","unstructured":"Jadvar H (2012) Molecular imaging of prostate cancer: PET radiotracers. AJR Am J Roentgenol 199(2):278\u2013291. https:\/\/doi.org\/10.2214\/ajr.12.8816","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"2794_CR8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2967\/jnumed.113.126094","volume":"54","author":"H Jadvar","year":"2013","unstructured":"Jadvar H (2013) Molecular imaging of prostate cancer with PET. J Nucl Med 54(10):1685\u20131688. https:\/\/doi.org\/10.2967\/jnumed.113.126094","journal-title":"J Nucl Med"},{"issue":"2","key":"2794_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cpet.2014.12.007","volume":"10","author":"H Jadvar","year":"2015","unstructured":"Jadvar H (2015) Prognostic utility of PET in prostate cancer. PET Clin 10(2):255\u2013263. https:\/\/doi.org\/10.1016\/j.cpet.2014.12.007","journal-title":"PET Clin"},{"issue":"12","key":"2794_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/pros.21173","volume":"70","author":"E Lin","year":"2010","unstructured":"Lin E, Wang Q, Swenson S, Jadvar H, Groshen S, Ye W, Markland FS, Pinski J (2010) The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo. Prostate 70(12):1359\u20131370. https:\/\/doi.org\/10.1002\/pros.21173","journal-title":"Prostate"},{"issue":"2","key":"2794_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3181\/00379727-219-44322","volume":"219","author":"MA McLane","year":"1998","unstructured":"McLane MA, Marcinkiewicz C, Vijay-Kumar S, Wierzbicka-Patynowski I, Niewiarowski S (1998) Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med Soc Exp Biol Med (New York, NY) 219(2):109\u2013119","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med (New York, NY)"},{"key":"2794_CR12","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.2741\/3177","volume":"13","author":"MA McLane","year":"2008","unstructured":"McLane MA, Joerger T, Mahmoud A (2008) Disintegrins in health and disease. Front Biosci 13:6617\u20136637","journal-title":"Front Biosci"},{"issue":"6","key":"2794_CR13","doi-asserted-by":"publisher","first-page":"e10929","DOI":"10.1371\/journal.pone.0010929","volume":"5","author":"RO Minea","year":"2010","unstructured":"Minea RO, Helchowski CM, Zidovetzki SJ, Costa FK, Swenson SD, Markland FS Jr (2010) Vicrostatin\u2014an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities. PLoS One 5(6):e10929. https:\/\/doi.org\/10.1371\/journal.pone.0010929","journal-title":"PLoS One"},{"issue":"5","key":"2794_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1025461507027","volume":"20","author":"JA Nemeth","year":"2003","unstructured":"Nemeth JA, Cher ML, Zhou Z, Mullins C, Bhagat S, Trikha M (2003) Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis 20(5):413\u2013420","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"2794_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000217975","volume":"17","author":"E Ruoslahti","year":"1996","unstructured":"Ruoslahti E (1996) Integrin signaling and matrix assembly. Tumour Biol 17(2):117\u2013124","journal-title":"Tumour Biol"},{"issue":"2","key":"2794_CR16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0021-9258(18)54042-4","volume":"268","author":"RM Scarborough","year":"1993","unstructured":"Scarborough RM, Naughton MA, Teng W, Rose JW, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF (1993) Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb\u2013IIIa. J Biol Chem 268(2):1066\u20131073","journal-title":"J Biol Chem"},{"issue":"27","key":"2794_CR17","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1200\/jco.2011.35.8648","volume":"29","author":"HI Scher","year":"2011","unstructured":"Scher HI, Morris MJ, Basch E, Heller G (2011) End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice. J Clin Oncol 29(27):3695\u20133704. https:\/\/doi.org\/10.1200\/jco.2011.35.8648","journal-title":"J Clin Oncol"},{"issue":"18","key":"2794_CR18","first-page":"4993","volume":"54","author":"M Trikha","year":"1994","unstructured":"Trikha M, De Clerck YA, Markland FS (1994a) Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res 54(18):4993\u20134998","journal-title":"Cancer Res"},{"issue":"1","key":"2794_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0049-3848(94)90052-3","volume":"73","author":"M Trikha","year":"1994","unstructured":"Trikha M, Rote WE, Manley PJ, Lucchesi BR, Markland FS (1994b) Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb Res 73(1):39\u201352","journal-title":"Thromb Res"},{"issue":"7","key":"2794_CR20","first-page":"1655","volume":"59","author":"DQ Zheng","year":"1999","unstructured":"Zheng DQ, Woodard AS, Fornaro M, Tallini G, Languino LR (1999) Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 59(7):1655\u20131664","journal-title":"Cancer Res"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-019-02794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-019-02794-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-019-02794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T23:43:08Z","timestamp":1611531788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-019-02794-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":20,"journal-issue":{"issue":"10-12","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2794"],"URL":"https:\/\/doi.org\/10.1007\/s00726-019-02794-3","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"3 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare. FSM and SS are co-founders of Disintegrin Therapeutics, Inc., but have no financial interest or official role in the Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving animals were in accordance with the ethical standards of the Institutional Animal Care and Use Committee (IACUC) at the University of Southern California (USC). This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}